Q4 2024 Earnings Call Transcript March 11, 2025 Exagen Inc. beats earnings expectations. Reported EPS is $-0.2, expectations ...

Our trailing 12-month average selling price increased to $411 for AVISE CTD, a gain of $75 per test over 2023 ... biomarkers as a powerful tool for SLE diagnosis as the publication details ...

Few experienced worry, confusion, fear, upset, or anger. The most common followup activities to viewing lab test result online were speaking with family or friends about the results, looking up ...

After hours: March 12 at 6:32:34 PM EDT Loading Chart for SLE ...

This indicates a successful year of strategic growth and operational efficiency. Exagen’s innovative product launches, such as new biomarkers for the Advise CTD test, contributed to this positive ...

After hours: March 14 at 7:59:46 PM EDT Loading Chart for RKLB ...

SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly injections already under review by the FDA.